Deep Vein Thrombosis Induced by Stasis in Mice Monitored by High Frequency Ultrasonography
April 13th, 2018
9.8K views
The present protocol describes the steps to obtain venous thrombosis using a stasis model. In addition, we are using a non-invasive method to measure thrombus formation and resolution over time.
Overview
This protocol outlines the procedure for inducing venous thrombosis in mice using a stasis model. It also describes a non-invasive method for monitoring thrombus formation and resolution over time.
Key Study Components
Area of Science
- Neuroscience
- Vascular biology
- Thrombosis research
Background
- Deep vein thrombosis (DVT) is a significant health concern.
- Understanding thrombus dynamics is crucial for developing treatments.
- Non-invasive imaging techniques can enhance research capabilities.
- The inferior vena cava stasis model is widely used in thrombosis studies.
Purpose of Study
- To induce DVT in a mouse model.
- To monitor thrombus formation and resolution using ultrasound.
- To investigate the effects of various agents on thrombus dynamics.
Methods Used
- Induction of DVT using the inferior vena cava stasis model.
- High frequency ultrasound for monitoring thrombus.
- Use of C57 black six mice for experimentation.
- Non-invasive quantification of thrombus formation and resolution.
Main Results
- Successful induction of venous thrombosis in mice.
- Effective monitoring of thrombus dynamics over time.
- Insights into the influence of pharmacological agents on thrombus behavior.
- Demonstration of the advantages of non-invasive imaging techniques.
Conclusions
- The stasis model is a reliable method for studying DVT.
- High frequency ultrasound provides valuable data on thrombus dynamics.
- This approach can facilitate research into therapeutic interventions for thrombosis.
Frequently Asked Questions
What is the purpose of the stasis model?
The stasis model is used to induce deep vein thrombosis for research purposes.
How is thrombus formation monitored?
Thrombus formation is monitored using high frequency ultrasound, allowing for non-invasive observation.
What type of mice are used in this study?
C57 black six mice are used for the experiments.
What are the advantages of this method?
The main advantage is the non-invasive quantification of thrombus formation and resolution.
How can this research impact thrombosis treatment?
It can provide insights into how different agents affect thrombus dynamics, aiding in treatment development.
Executive Industry Relevance
Non-invasive, quantitative monitoring of thrombus formation and resolution in murine models enables robust evaluation of pharmacological, genetic, or cellular interventions in thrombosis research. High frequency ultrasonography provides translationally relevant, reproducible data that supports early-stage target validation and mechanistic de-risking for vascular and hematological drug discovery. This approach reduces animal usage and enhances predictive confidence at critical preclinical inflection points.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of therapeutic hypotheses regarding thrombosis mechanisms and intervention points.
- Supports functional validation of targets influencing thrombus formation or resolution in vivo.
- Facilitates mechanistic de-risking by allowing longitudinal assessment of intervention effects.
- Provides quantitative endpoints for portfolio triage and early go/no-go decisions.
Screening & Assay Development
- Establishes a validated, reproducible in vivo system for evaluating candidate compounds or genetic modifications.
- Delivers standardized, quantitative measurements of thrombus size and blood flow velocity.
- Enables scalable, non-terminal assessment of intervention efficacy across cohorts.
- Supports assay readiness for downstream translational and preclinical workflows.
Translational & Preclinical Research
- Aligns preclinical models with human disease-relevant endpoints through imaging-based quantification.
- Enables continuity from discovery through preclinical validation by tracking thrombus dynamics over time.
- Supports risk-adjusted advancement decisions based on robust, longitudinal data.
- Facilitates biomarker alignment by correlating imaging, histological, and molecular endpoints.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by providing a platform for hypothesis testing, intervention screening, and translational validation in thrombosis research.
- Discovery Biology: Supports hypothesis-driven studies of thrombosis mechanisms and intervention effects.
- Screening: Provides reproducible, quantitative outputs for compound or genetic screening in vivo.
- Analytics: Enables measurement of thrombus size, blood flow velocity, and temporal resolution for comparative analysis.
- Translational Research: Bridges discovery and preclinical phases by enabling longitudinal, non-invasive monitoring aligned with clinical imaging endpoints.
- Enterprise Reuse: Offers a reusable, standardized platform for diverse thrombosis-related research and intervention testing.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in thrombosis target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of in vivo thrombosis studies.
- Strategic Value: Improves go/no-go decision quality and capital efficiency by providing robust, quantitative data.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of thrombosis-related assets.
Implementation Considerations
- Requires expertise in murine surgical models and high frequency ultrasonography.
- Demands access to advanced imaging instrumentation and analytical infrastructure.
- Necessitates rigorous cross-team standardization of surgical and imaging protocols.
- Adaptation may be needed for different mouse strains or thrombosis models.
- Careful procedural execution is critical to avoid vessel rupture and ensure data integrity.
Biopharma FAQs
Why does null hypothesis testing matter for thrombus quantification?
Null hypothesis testing enables objective evaluation of whether pharmacological or genetic interventions significantly alter thrombus size or resolution, supporting robust target validation and mechanistic de-risking in thrombosis research.
How does independent variable isolation fit the stasis model workflow?
Systematic ligation of IVC side branches ensures that thrombus formation is attributable to the intended intervention, minimizing confounding variables and increasing the reliability of mechanistic insights.
What do quantitative ultrasound measurements enable in thrombosis studies?
Quantitative ultrasonography provides reproducible data on thrombus size and blood flow velocity, enabling direct comparison of intervention effects and supporting data-driven advancement decisions.
Why are replication requirements critical for cross-functional thrombosis research?
Replication ensures that observed effects on thrombus formation or resolution are consistent and reproducible, facilitating cross-team data integration and supporting enterprise-level portfolio decisions.
Which statistical analysis capabilities are required before implementing ultrasound quantification?
Robust statistical analysis is needed to compare thrombus measurements across groups, validate correlations with histological endpoints, and ensure that findings meet preclinical decision thresholds for advancement.
